2008 - Intensive glucose control did not prevent important complications in type 2 diabetes
- Stop prediabetes to prevent Type 2, urge experts. Nelson, Roxanne // Drug Topics;Oct2002 Supplement, Vol. 146 Issue 19, p23
Reports the increase incidence of Type 2 diabetes mellitus in the U.S. Normality of the glucose tolerance; Calculation of the prevalence of prediabetes; Accounts on the risk factors for cardiovascular disease.
- SGLT2 INHIBITION: A NOVEL WAY TO TREAT TYPE 2 DIABETES. Fonseca, Vivian // Endocrine Today;Dec2011 Supplement, p8
The article discusses the role of sodium-dependent glucose transporters or sensors (SGLT2) inhibitor in the treatment of type 2 diabetes.
- Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes. // New England Journal of Medicine;9/3/2009, Vol. 361 Issue 10, p1028
A correction to the article "Glucose Control and Vascular Complications in Veterans With Type 2 Diabetes" that was published in the January 8, 2009 issue is presented.
- DIABETES TODAY: A startling new body of knowledge. Nemchik, Rita // RN;Oct82, Vol. 45 Issue 10, p30
Presents updates on diabetes research as of October 1982. Description of insulin-dependent diabetes mellitus; Clinical characteristics of non-insulin-dependent diabetes mellitus; Discussion on impaired glucose tolerance. INSET: DIABETES: THE WAR IS FAR FROM WON.
- TINSAL-T2D: Salsalate lowered glucose in patients with type 2 diabetes. Costa, Samantha; Fisher, Stacey; Foster, Melissa; Kalvaitis, Katie // Endocrine Today;Jul2012, Vol. 10 Issue 7, p20
The article reports that the results of a Targeting Inflammation Using Salsalate for Type 2 Diabetes (TINSAL-T2D) trial revealed the effectiveness of salsalate in reducing glucose in patients with type 2 diabetes.
- Is Alc Always the Best Game in Town to Monitor Type 2 Diabetes? // Infectious Disease Alert;Nov2012 Clinical Briefs in Primary Care, p22
The article focuses on the limitations of A1C in monitoring Type 2 Diabetes due to the process' use of hemoglobin that needs to be exposed to excess glucose for the entire life of a red cell.
- Molecular Switch Could Be Key for Type 2s. Wirestone, Clay // Diabetes Health Professional;Jun/Jul2012, Vol. 21 Issue 3, p15
The article discusses research from California's Salk Institute, which found that regulation of CREB regulated transcription co-activator 2 (CRTC), a genetic switch, could slow down the production of blood sugar in insulin-resistant type 2 diabetes patients.
- Intrahepatic Mechanisms Underlying the Effect of Metformin in Decreasing Basal Glucose Production in Rats Fed a High-Fat Diet. Mithieux, Gilles; Guignot, Ludovic; Bordet, Jean-Claude; Wiernsperger, Nicolas // Diabetes;Jan2002, Vol. 51 Issue 1, p139
Examines the effects of metformin in decreasing basal glucose production in rats. Details on the intrahepatic mechanism metformin; Importance of metformin in treating patients with type 2 diabetes; Determinants of hepatic glucose production.
- Mechanism by which metformin reduces glucose production in type 2 diabetes. Hundal, Ripudaman S.; Krssak, Martin; Dufour, Sylvie; Laurent, Didier; Lebon, Vincent; Chandramouli, Visvanathan; Inzucchi, Silvio E.; Hundal, R S; Krssak, M; Dufour, S; Laurent, D; Lebon, V; Chandramouli, V; Inzucchi, S E; Schumann, W C; Petersen, K F; Landau, B R; Shulman, G I // Diabetes;Dec2000, Vol. 49 Issue 12, p2063
To examine the mechanism by which metformin lowers endogenous glucose production in type 2 diabetic patients, we studied seven type 2 diabetic subjects, with fasting hyperglycemia (15.5 +/- 1.3 mmol/l), before and after 3 months of metformin treatment. Seven healthy subjects, matched for sex,...